| Literature DB >> 35295017 |
Emnet Getachew1, Yimtubezinash Woldeamanuel2, Tsegahun Manyazewal2.
Abstract
Background: Digital health technologies are emerging as promising technologies to advance clinical care. This study aimed to assess providers' perceptions and acceptability of digital health interventions (DHIs) in the clinical care and treatment of tuberculosis (TB) and HIV in Addis Ababa, Ethiopia.Entities:
Keywords: Digital health; Ethiopia technology; electronic health; healthcare providers; human immunodeficiency virus; tuberculosis
Mesh:
Year: 2022 PMID: 35295017 PMCID: PMC9400110 DOI: 10.4103/ijmy.ijmy_235_21
Source DB: PubMed Journal: Int J Mycobacteriol ISSN: 2212-5531
Figure 1:Unified theory of acceptance and use of technology framework
Figure 2:Unified theory of acceptance and use of technology model for the assessment of acceptability and perception of using digital health interventions
Included public health centers from each sub-city
| Name of health center | Sub-city |
|---|---|
| Addis Raey health center | Addis ketema |
| Akaki health center | Akaki kality |
| Kebena health center | Arada |
| Goro health center | Bole |
| Adisu Gebeya health center | Gulele |
| Kazanchis health center | Kirkos |
| Alem Bank health center | Kolfe |
| Teklehaymanot health | Lideta |
| Woreda 2 health center | Nifasilk lafto |
| Woreda 13 health center | Yeka |
Sociodemographic characteristics
| Total | 60 (100) |
| Gender | |
| Male | 24 (40) |
| Female | 36 (60) |
| Age | |
| 18–30 | 16 (26.7) |
| 31–40 | 25 (41.7) |
| 41–50 | 15 (25) |
| Above 51 | 4 (6.7) |
| Educational level | |
| College diploma | 10 (16.7) |
| BSc | 39 (65) |
| MSc | 11 (18.3) |
| Department | |
| TB room | 23 (38.3) |
| HIV room | 37 (61.7) |
| Work experience | |
| <1 year | 2 (3.3) |
| 2–5 | 16 (26.7) |
| 6–9 | 20 (33.3) |
| Above 10 | 22 (36.7) |
TB: Tuberculosis, HIV: Human immunodeficiency virus
Responses of leading questions by the respondents
| Leading questions | Percent of cases |
|---|---|
| Q1[ | |
| HCPs heard of DHIs | 48.3 |
| HCPs with smart phone | 85.0 |
| Willingness to use various technologies in the facility | 90 |
| Computer access in the health-care facility | 55.0 |
| HCPs having different online training | 11.7 |
| Experience using EMR | 61.7 |
| Experience in using any other technologies for TB/HIV patients | 80.0 |
| The relative advantage of technology | 75.0 |
| The simplicity of the technology | 70.0 |
| Related training that would help to implement such technology | 68.3 |
| Adequacy of the training | 26.7 |
| Favorable environment or infrastructure | 43.3 |
| Challenges to use DHIs in the facility? | 86.7 |
| Opportunities in the facility to adopt new DHIs? | 81.7 |
Question 1. HCPs: Health-care providers, DHIs: Digital health interventions, EMR: Electronic medical record, TB: Tuberculosis, HIV: Human immunodeficiency virus
Direct speech of the respondents
| Response |
|---|
|
Performance expectancy “We can retrieve patient data from electronically recorded documents easily as compared with manual work documentation; besides the systems do have numerous advantages that simplify service delivery and decision-making process”. HCPs from HIV clinic “I think smart care has made our work much easier. Before there were a lot of missing data of the patients but currently any important information can be easily accessed by the care providers”. HCPs from HIV clinic “The digital adherence technology reduced the workload and increased our job satisfaction which allows us to dedicate more time to other tasks”. HCPs from TB clinic “Previously we were supposed to give therapy on a daily basis (i.e., DOT). But now, the patients come (to the clinic) every 15 days so that our work pressure has been reduced consequently”. HCPs from TB clinic “I am not sure whether they have taken the medication or not thus i prefer DOT”. HCPs from TB clinic Effort expectancy “We took two weeks training on how to use the smart care and consequently it likely becomes very easy to work with it as a result of its utilization”. HCPs from HIV clinic “I found the drug adherence technology is easy to use. I have not yet faced any difficulties so far to use it.” HCPs from TB clinic “With a simple orientation I was given, I found the task was very difficult for I have no previous experience on using such technologies, but currently I can use the device more easily after sometimes of exposure.” HCPs from TB clinic Social norm “Patients now need not travel long distances spending their money and time to collect their drugs every day. Most of our TB patients come from distant villages. Now, they feel comfortable with being supported by these technologies.” HCPs from TB clinic “Previously most patients come to the clinic with lost cards and it was difficult to manage such issues but currently since the patient’s card number is registered electronically as a result of this the problem is being solved. Therefore, the patients are happy with the new technology” HCPs from HIV clinic “The good thing about the digital adherence technology is that it does not carry any messages on TB [on the outside of the box], so there is no stigma attached to it. This helps the patients to carry it freely”. HCPs from TB clinic Facilitating conditions “Here in our offices, we have enough computers so we can perform our work more easily than before”. HCPs from HIV clinic “Even if there is Wi-Fi access in the health facility, the signal is a bit weak to work with it efficiently”. HCPs from TB clinic “We had two weeks of training on smart care to implement it; besides, the management members are very supportive. There are also enough number computers, Wi-Fi access and generator; so, this would facilitate our work”. HCPs from HIV clinic “In our room, there are no computers and the one that we had used previously is not yet maintained; so, we have borrowed some computers from another room and this makes our works very difficult for there is a very limited number of computers to use in the health facility.” HCPs from TB clinic |
HCPs: Healthcare providers, HIV: Human immunodeficiency virus, TB: Tuberculosis
Model summary
| Model |
|
| Adjusted | SE of the estimate | Change statistics | ||||
|---|---|---|---|---|---|---|---|---|---|
| Df1 | Df2 | Significant | |||||||
| 1 | 0.436[ | 0.540 | 0.515 | 0.461 | 0.590 | 2.536 | 5 | 54 | 0.030[ |
Predictors: Constant, work experience, department, educational level, sex, age,
Dependent variable: Willingness to use the technology. SE: Standard error
ANOVA table
| Model | Sum of squares | Df | Mean square |
| Significant |
|---|---|---|---|---|---|
| 1 | |||||
| Regression | 2.697 | 4 | 0.539 | 15.536 | 0.030[ |
| Residual | 11.486 | 54 | 0.213 | ||
| Total | 14.183 | 59 |
Dependent variable: Willingness to use the technology,
Predictors: Constant, work experience, department, educational level, sex, age
Table of coefficients
| Model | Unstandardized coefficients | Standardized coefficients |
| Significant | Correlations | Collinearity statistics | ||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| SE | Beta | Zero-order | Partial | Part | Tolerance | VIF | |||
| Constant | 1.611 | 0.346 | 4.655 | 0.000 | ||||||
| Education | 0.080 | 0.102 | 0.097 | 3.784 | 0.006 | 0.152 | 0.106 | 0.096 | 0.974 | 1.027 |
| Sex | 0.055 | 0.127 | 0.055 | 0.433 | 0.666[ | 0.056 | 0.059 | 0.053 | 0.916 | 1.092 |
| Department | 0.056 | 0.073 | 0.100 | 0.767 | 0.085 | −0.051 | 0.104 | 0.094 | 0.875 | 1.143 |
| Age | −0.227 | 0.129 | −0.227 | −1.757 | 0.027[ | −0.199 | −0.233 | −0.215 | 0.896 | 1.116 |
| Experience | −0.203 | 0.071 | −0.366 | −2.855 | 0.016[ | −0.362 | −0.362 | −0.350 | 0.913 | 1.095 |
Dependent variable: Willingness to use the technology. SE: Standard error, VIF: Variance inflation factor
Figure 3:Probability plot of regression standardized residual